Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

John Gerard Clohessy, Ph.D.

Concepts (338)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with John Clohessy's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that John Clohessy has written about over time.
BH3 Interacting Domain Death Agonist Protein, 1 publications between 2005 and 2005, average publication date December 2005. Cytochromes c, 1 publications between 2005 and 2005, average publication date December 2005. Neoplasm Proteins, 4 publications between 2004 and 2021, average publication date October 2009. TOR Serine-Threonine Kinases, 4 publications between 2009 and 2016, average publication date June 2012. Tumor Suppressor Protein p53, 8 publications between 2007 and 2018, average publication date February 2013. Tumor Suppressor Proteins, 4 publications between 2008 and 2019, average publication date March 2013. Drug Evaluation, Preclinical, 3 publications between 2013 and 2015, average publication date March 2014. PTEN Phosphohydrolase, 14 publications between 2009 and 2020, average publication date December 2014. Mice, 41 publications between 2004 and 2024, average publication date January 2016. Disease Models, Animal, 11 publications between 2009 and 2020, average publication date March 2016. Prostatic Neoplasms, 11 publications between 2010 and 2020, average publication date July 2016. Proto-Oncogene Proteins c-akt, 7 publications between 2009 and 2024, average publication date June 2017. Carcinoma, Non-Small-Cell Lung, 6 publications between 2006 and 2024, average publication date May 2018. Drug Resistance, Neoplasm, 7 publications between 2015 and 2021, average publication date October 2018. Anilides, 2 publications between 2017 and 2020, average publication date January 2019. Antineoplastic Agents, 7 publications between 2013 and 2024, average publication date January 2019. Xenograft Model Antitumor Assays, 8 publications between 2014 and 2024, average publication date August 2019. Leukemia, Promyelocytic, Acute, 2 publications between 2019 and 2021, average publication date March 2020.

To see the data from this visualization as text, click here.
Clohessy's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (338)
Explore
_
Co-Authors (72)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.